123 related articles for article (PubMed ID: 35793396)
41. Lanthionine synthetase components C-like 2 increases cellular sensitivity to adriamycin by decreasing the expression of P-glycoprotein through a transcription-mediated mechanism.
Park S; James CD
Cancer Res; 2003 Feb; 63(3):723-7. PubMed ID: 12566319
[TBL] [Abstract][Full Text] [Related]
42. Simultaneous delivery of chemotherapeutic and thermal-optical agents to cancer cells by a polymeric (PLGA) nanocarrier: an in vitro study.
Tang Y; Lei T; Manchanda R; Nagesetti A; Fernandez-Fernandez A; Srinivasan S; McGoron AJ
Pharm Res; 2010 Oct; 27(10):2242-53. PubMed ID: 20694526
[TBL] [Abstract][Full Text] [Related]
43. MDR1 inhibition increases sensitivity to doxorubicin and etoposide in adrenocortical cancer.
Creemers SG; van Koetsveld PM; De Herder WW; Dogan F; Franssen GJH; Feelders RA; Hofland LJ
Endocr Relat Cancer; 2019 Mar; 26(3):367-378. PubMed ID: 30650062
[TBL] [Abstract][Full Text] [Related]
44. Modulation of telomerase and signal transduction proteins by hexyl-ALA-photodynamic therapy (PDT) in human doxorubicin resistant cancer cell models.
Chu ES; Yow CM
Photodiagnosis Photodyn Ther; 2012 Sep; 9(3):243-55. PubMed ID: 22959804
[TBL] [Abstract][Full Text] [Related]
45. Multidrug-resistant human sarcoma cells with a mutant P-glycoprotein, altered phenotype, and resistance to cyclosporins.
Chen G; Durán GE; Steger KA; Lacayo NJ; Jaffrézou JP; Dumontet C; Sikic BI
J Biol Chem; 1997 Feb; 272(9):5974-82. PubMed ID: 9038218
[TBL] [Abstract][Full Text] [Related]
46. Blockade of c-Met-Mediated Signaling Pathways by E7050 Suppresses Growth and Promotes Apoptosis in Multidrug-Resistant Human Uterine Sarcoma Cells.
Huang TT; Chen CM; Lan YW; Lin SS; Choo KB; Chong KY
Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499211
[TBL] [Abstract][Full Text] [Related]
47. Cytotoxic effects of 15-deoxy-Δ12,14-prostaglandin J2 alone and in combination with dasatinib against uterine sarcoma
Kawakita T; Masato N; Takiguchi E; Abe A; Irahara M
Exp Ther Med; 2017 Jun; 13(6):2939-2945. PubMed ID: 28587364
[TBL] [Abstract][Full Text] [Related]
48. Metabolic conversion of methoxymorpholinyl doxorubicin: from a DNA strand breaker to a DNA cross-linker.
Lau DH; Duran GE; Lewis AD; Sikic BI
Br J Cancer; 1994 Jul; 70(1):79-84. PubMed ID: 8018545
[TBL] [Abstract][Full Text] [Related]
49. Selection of non-P-glycoprotein mediated high-level etoposide resistant cell lines by adriamycin with P-gp inhibitors.
Ades S; Maxfield LF; Gould CJ; Jones GK; Levy SB
Int J Oncol; 2006 Mar; 28(3):747-53. PubMed ID: 16465381
[TBL] [Abstract][Full Text] [Related]
50. Wnt pathway activation and ABCB1 expression account for attenuation of proteasome inhibitor-mediated apoptosis in multidrug-resistant cancer cells.
Chong KY; Hsu CJ; Hung TH; Hu HS; Huang TT; Wang TH; Wang C; Chen CM; Choo KB; Tseng CP
Cancer Biol Ther; 2015; 16(1):149-59. PubMed ID: 25590413
[TBL] [Abstract][Full Text] [Related]
51. Knockdown of c-MET induced apoptosis in ABCB1-overexpressed multidrug-resistance cancer cell lines.
Hung TH; Li YH; Tseng CP; Lan YW; Hsu SC; Chen YH; Huang TT; Lai HC; Chen CM; Choo KB; Chong KY
Cancer Gene Ther; 2015 May; 22(5):262-70. PubMed ID: 25908454
[TBL] [Abstract][Full Text] [Related]
52. 17 beta-estradiol glucuronide: an inducer of cholestasis and a physiological substrate for the multidrug resistance transporter.
Gosland M; Tsuboi C; Hoffman T; Goodin S; Vore M
Cancer Res; 1993 Nov; 53(22):5382-5. PubMed ID: 8106146
[TBL] [Abstract][Full Text] [Related]
53. Genetic and epigenetic modeling of the origins of multidrug-resistant cells in a human sarcoma cell line.
Chen KG; Wang YC; Schaner ME; Francisco B; Durán GE; Juric D; Huff LM; Padilla-Nash H; Ried T; Fojo T; Sikic BI
Cancer Res; 2005 Oct; 65(20):9388-97. PubMed ID: 16230402
[TBL] [Abstract][Full Text] [Related]
54. 5-Oxo-hexahydroquinoline Derivatives and Their Tetrahydroquinoline Counterparts as Multidrug Resistance Reversal Agents.
Shahraki O; Khoshneviszadeh M; Dehghani M; Mohabbati M; Tavakkoli M; Saso L; Edraki N; Firuzi O
Molecules; 2020 Apr; 25(8):. PubMed ID: 32316291
[TBL] [Abstract][Full Text] [Related]
55. Photochemical internalization of therapeutic macromolecular agents: a novel strategy to kill multidrug-resistant cancer cells.
Selbo PK; Weyergang A; Bonsted A; Bown SG; Berg K
J Pharmacol Exp Ther; 2006 Nov; 319(2):604-12. PubMed ID: 16902053
[TBL] [Abstract][Full Text] [Related]
56. MDR 1 activation is the predominant resistance mechanism selected by vinblastine in MES-SA cells.
Chen GK; Durán GE; Mangili A; Beketic-Oreskovic L; Sikic BI
Br J Cancer; 2000 Oct; 83(7):892-8. PubMed ID: 10970691
[TBL] [Abstract][Full Text] [Related]
57. Synthesis and cytotoxic activity of a new potent daunomycinone derivative.
Aligiannis N; Pouli N; Marakos P; Skaltsounis AL; Pratsinis H
Bioorg Med Chem Lett; 2002 Dec; 12(24):3505-7. PubMed ID: 12443763
[TBL] [Abstract][Full Text] [Related]
58. Preferential expression of a mutant allele of the amplified MDR1 (ABCB1) gene in drug-resistant variants of a human sarcoma.
Chen KG; Lacayo NJ; Durán GE; Wang Y; Bangs CD; Rea S; Kovacs M; Cherry AM; Brown JM; Sikic BI
Genes Chromosomes Cancer; 2002 Aug; 34(4):372-83. PubMed ID: 12112526
[TBL] [Abstract][Full Text] [Related]
59. Synthesis, Biological Evaluation and Stability Studies of Some Novel Aza-Acridine Aminoderivatives.
Karelou M; Kourafalos V; Tragomalou AP; Marakos P; Pouli N; Tsitsilonis OE; Gikas E; Kostakis IK
Molecules; 2020 Oct; 25(19):. PubMed ID: 33049986
[TBL] [Abstract][Full Text] [Related]
60. In vitro efficacy of doxorubicin and etoposide against a feline injection site sarcoma cell line.
Hill J; Lawrence J; Saba C; Turek M; Feldhaeusser B; Coutermarsh-Ott S; Barber J; Smith J; Gogal R
Res Vet Sci; 2014 Oct; 97(2):348-56. PubMed ID: 25085537
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
